February 12, 2016
Recommended Topic Related To:


"Glaucoma is a group of diseases that damage the optic nerve, a cable at the back of each eye that connects it to the brain. It affects more than 2.7 million people in the United States and more than 60 million worldwide. There are many forms of t"...



How Supplied


BETAGAN® (levobunolol) ophthalmic solution has been shown to be effective in lowering intraocular pressure and may be used in patients with chronic open-angle glaucoma or ocular hypertension.


The recommended starting dose is one to two drops of BETAGAN® (levobunolol) ophthalmic solution 0.5% in the affected eye(s) once a day. Typical dosing with BETAGAN® (levobunolol) 0.25% is one to two drops twice daily. In patients with more severe or uncontrolled glaucoma, BETAGAN® (levobunolol) 0.5% can be administered b.i.d. As with any new medication, careful monitoring of patients is advised. Dosages above one drop of BETAGAN® (levobunolol) 0.5% b.i.d. are not generally more effective. If the patient's IOP is not at a satisfactory level on this regimen, concomitant therapy with dipivefrin and/or epinephrine, and/or pilocarpine and other miotics, and/or systemically administered carbonic anhydrase inhibitors, such as acetazolamide, can be instituted. Patients should not typically use two or more topical ophthalmic beta-adrenergic blocking agents simultaneously.


BETAGAN® (levobunolol hydrochloride ophthalmic solution USP) Liquifilm® sterile ophthalmic solution is supplied in white opaque plastic dropper bottles as follows:

BETAGAN 0.25%: C Cap® Compliance Cap B.I.D. (twice daily)
  5 mL--NDC 11980-469-25 10 mL--NDC 11980-469-20
BETAGAN 0.5%: Standard Cap C Cap® Compliance Cap C CAP® Compliance Cap
2 mL--NDC 11980-252-02 Q.D.(once daily) B.I.D. (twice daily)
  5 mL--NDC 11980-252-65 5 mL--NDC 11980-252-25
  10 mL--NDC 11980-252-60 10 mL--NDC 11980-252-20
  15 mL--NDC 11980-252-61 15 mL--NDC 11980-252-21

NOTE: Protect from light. Store at 15°-30°C (59°-86°F).

Allergan Inc, Irvine, Califomia 29612, U.S.A. FDA rev date: 4/12/2002

This monograph has been modified to include the generic and brand name in many instances.

Last reviewed on RxList: 10/20/2008

How Supplied

Report Problems to the Food and Drug Administration


You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

WebMD Daily

Get breaking medical news.

Health Resources
Use Pill Finder Find it Now See Interactions

Pill Identifier on RxList

  • quick, easy,
    pill identification

Find a Local Pharmacy

  • including 24 hour, pharmacies

Interaction Checker

  • Check potential drug interactions
Search the Medical Dictionary for Health Definitions & Medical Abbreviations